Bhavesh Mohan Lal, MD, UAMS College of Medicine, Little Rock, Arkansas, reviews a study designed to investigate the effects of prior exposure to BCMA-targeting agents on outcomes with…
Praneeth Reddy Sudalagunta, PhD, applied research scientist, Moffitt Cancer Center, Tampa, Florida, discusses the differential effects of bridging therapy on the immune microenvironment as well as outcomes with…
NEW YORK (Reuters Health) – In a study of childhood cancer survivors, treatment with total body or abdominal irradiation was associated with an increased risk of diabetes later…
NEW YORK (Reuters Health) – Having a first-degree relative with breast cancer may slightly increase a person’s risk of colorectal cancer, Canadian researchers report in the International Journal…
NEW YORK (Reuters Health) – Therapy with denosumab appears to augment bone mineral density and lower the risk of fracture among men with prostate cancer undergoing androgen-deprivation therapy,…
NEW YORK (Reuters Health) – Don’t assume that lower limb salvage yields better functional and quality-of-life outcomes than amputation for children and adolescents with bone and soft tissue…
NEW YORK (Reuters Health) – Ovarian- and uterine-conserving surgery appears to be safe in premenopausal women with stage IA or IC epithelial ovarian cancer, with no adverse impact…
NEW YORK (Reuters Health) – As first-line therapy for advanced chronic lymphocytic leukemia, bendamustine produced significantly higher response rates and longer progression-free survival than chlorambucil in a phase…
NEW YORK (Reuters Health) – Both progression-free and overall survival are extended in patients with advanced non-small cell lung cancer treated with erlotinib following standard chemotherapy, according to…
NEW YORK (Reuters Health) – Due to hemoglobin degradation, delayed return of fecal occult blood tests (FOBTs) may miss colorectal adenomas and possibly also overt malignancy, according to…
NEW YORK (Reuters Health) – INR testing intervals of 4 weeks or less are typically recommended for patients on long-term warfarin therapy, but new research suggests that less…
NEW YORK (Reuters Health) – Allogeneic blood transfusions in patients who undergo coronary artery bypass graft surgery (CABG) substantially increase the patient’s odds of nosocomial infection, hospital readmission…
